Chronic Respiratory Diseases in the Regions of Northern Russia: Epidemiological Distinctions in the Results of a National Population Study

Gambaryan, Marine; Шальнова, С. А.; Деев, А. Д.; Drapkina, О. М.

doi:10.3390/ijerph14080841

Cited by 8 publications

(9 citation statements)

References 12 publications

(12 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The epidemiology and disease burdens of CRDs vary substantially worldwide. Previous studies have estimated the prevalence of CRDs at the regional or national level but not at the global level [3][4][5]. Understanding the prevalence and incidence trends of CRDs is vital for improving the control and prevention of CRDs.…”

Section: Introductionmentioning

confidence: 99%

Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017

et al. 2020

View full text Add to dashboard Cite

Background: Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs have not been estimated. Methods: Based on data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, we analyzed the prevalence and incidence trends of CRDs from 1990 to 2017 according to age, sex, region and disease pattern. Furthermore, the correlations between the incidence and the World Bank income levels, sociodemographic index (SDI), and human development index (HDI) levels were analyzed to assess the factors affecting incidence.Result: The total number of CRD cases increased by 39.5% from 1990 to 2017, nevertheless, the age-standardized prevalence rate (ASPR) and age-standardized incidence rate (ASIR) showed decreasing trends. The ASIRs of CRD, chronic obstructive pulmonary disease (COPD), pneumoconiosis, and asthma decreased, whereas the ASIR of interstitial lung disease and pulmonary sarcoidosis increased during the past 27 years. Significant differences between males and females in the incidence rates of pneumoconiosis, interstitial lung disease and pulmonary sarcoidosis were observed. Elderly people especially suffered from CRDs, except for asthma. For COPD, the ASIR decreased from low-SDI regions to high-SDI regions. The ASIR of interstitial lung disease and pulmonary sarcoidosis in the high-SDI region was highest and have increased mostly. The ASIRs for pneumoconiosis and asthma were inversely related to the HDI. Conclusions:In 2017, CRDs were still the leading causes of morbidity worldwide. A large proportion of the disease burden was attributed to asthma and COPD. The incidence rates of all four types of CRDs varied greatly across the world. Statistically significant correlation was found between the ASIR and SDI/HDI.

show abstract

Section: Introductionmentioning

confidence: 99%

Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017

et al. 2020

View full text Add to dashboard Cite

show abstract

“…We speculate that both the underlying population, region and local risk factors, the way the diagnosis was made, and underdiagnosis of COPD may play a role in explaining these differences. Artukhov et al [ 19 ] and Chuchalin et al [ 20 ] used stratified random cluster sampling; Gambaryan et al [ 21 ] selected subjects from the clinics. Notably, in many Central Asian countries, due to cultural and socioeconomic circumstances, patients go to the hospital only when the condition worsens, and not when the first symptoms appear, which also affects the underdiagnosis of RDs.…”

Section: Discussionmentioning

confidence: 99%

“…For example, Landis et al [ 22 ] recruited 301 participants of 40 years and older in Russia, and estimated the prevalence of COPD, based on a broad definition of self-reported physician diagnosis of COPD or chronic bronchitis or symptoms matching chronic bronchitis, at 9.2%. Artukhov et al [ 19 ], Gambaryan et al [ 21 ], and Chuchalin et al [ 20 ] found that the prevalence of COPD in Russia was 2%, 15.7%, and 15.3%. Age groups were ≥18 years old, 35–64 years old, and ≥18 years old, respectively.…”

Section: Discussionmentioning

confidence: 99%

“…In contrast, participants in Chuchalin et al [ 20 ] completed a questionnaire and then performed spirometry with bronchodilator testing (FEV 1 /FVC < 0.7) if obstruction was observed. Gambaryan et al [ 21 ] used only a questionnaire, but this was relatively broad and only considered COPD if patients were >40 years. This makes it difficult to directly compare these data.…”

Section: Discussionmentioning

confidence: 99%

“… Overview of geographic locations of respiratory disease prevalence studies in Russia and Central Asia. (1) Russia (nationwide) [ 12 ]; (2) Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, Russia (nationwide) [ 13 ]; (3) Kazakhstan (nationwide) [ 14 ]; (4) Almaty, Kazakhstan [ 26 ]; (5) Almaty, Kazakhstan [ 23 ]; (6) Uzbekistan [ 16 ]; (7) Sughd province, Tajikistan [ 15 ]; (8) Vladimir region, Russia [ 17 ]; (9) Murmansk region, Russia [ 18 ]; (10) Krasnoyarsk region, Russia [ 19 ]; (11) Moscow, Russia [ 29 ]; (12) Altay region, Russia [ 28 ]; (13) St. Petersburg, Russia [ 25 ]; (14) Russia [ 20 ]; (15) Vologda, Chelyabinsk, Yakutsk, Russia [ 21 ]; (16) Russia [ 22 ]; (17) St. Petersburg and Arkhangelsk, Russia [ 24 ]; and (18) Nikel, Russia [ 27 ]. …”

Section: Figurementioning

confidence: 99%

See 2 more Smart Citations

Prevalence and Economic Burden of Respiratory Diseases in Central Asia and Russia: A Systematic Review

Tabyshova

Emilov

Postma

et al. 2020

IJERPH

View full text Add to dashboard Cite

Prevalence data of respiratory diseases (RDs) in Central Asia (CA) and Russia are contrasting. To inform future research needs and assist government and clinical policy on RDs, an up-to-date overview is required. We aimed to review the prevalence and economic burden of RDs in CA and Russia. PubMed and EMBASE databases were searched for studies that reported prevalence and/or economic burden of RDs (asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, interstitial lung diseases (ILD), lung cancer, pulmonary hypertension, and tuberculosis (TB)) in CA (Kyrgyzstan, Uzbekistan, Tajikistan, Kazakhstan, and Turkmenistan) and Russia. A total of 25 articles (RD prevalence: 18; economics: 7) were included. The majority (n = 12), mostly from Russia, reported on TB. TB prevalence declined over the last 20 years, to less than 100 per 100,000 across Russia and CA, yet in those, multidrug-resistant tuberculosis (MDR-TB) was alarming high (newly treated: 19–26%, previously treated: 60–70%). COPD, asthma (2–15%) and ILD (0.006%) prevalence was only reported for Russia and Kazakhstan. No studies on cystic fibrosis, lung cancer and pulmonary hypertension were found. TB costs varied between US$400 (Tajikistan) and US$900 (Russia) for drug-susceptible TB to ≥US$10,000 for MDR-TB (Russia). Non-TB data were scarce and inconsistent. Especially in CA, more research into the prevalence and burden of RDs is needed.

show abstract

Time trends in smoking in Russia in the light of recent tobacco control measures: synthesis of evidence from multiple sources

et al. 2020

Self Cite

View full text Add to dashboard Cite

Background The study aims at identifying long-term trends and patterns of current smoking by age, gender, and education in Russia, including the most recent period from 2008 during which tobacco control policies were implemented, and to estimate the impact on mortality of any reductions in prevalence. We present an in-depth analysis based on an unprecedentedly large array of survey data. Methods We examined pooled micro-data on smoking from 17 rounds of the Russian Longitudinal Monitoring Study of 1996–2016, 11 other surveys conducted in Russia in 1975–2017, and two comparator surveys from England and the USA. Standardization by age and education, regression and meta-analysis were used to estimate trends in the prevalence of current smoking by gender, age, and educational patterns. Results From the mid-1970s to the mid-2000s smoking prevalence among men was relatively stable at around 60%, after which time prevalence declined in every age and educational group. Among women, trends in smoking were more heterogeneous. Prevalence more than doubled above the age of 55 years from very low levels (< 5%). At younger ages, there were steep increases until the mid-2000s after which prevalence has declined. Trends differed by educational level, with women in the lowest educational category accounting for most of the long-term increase. We estimate that the decline in male smoking may have contributed 6.2% of the observed reduction in cardiovascular deaths among men in the period 2008–16. Conclusions The implementation of an effective tobacco control strategy in Russia starting in 2008 coincided with a decline in smoking prevalence among men from what had been stable, high levels over many decades regardless of age and education. Among women, the declines have been more uneven, with young women showing recent downturns, while the smoking prevalence in middle age has increased, particularly among those with minimal education. Among men, these positive changes will have made a small contribution to the reduction in mortality seen in Russia since 2005.

show abstract

Chronic Respiratory Diseases in the Regions of Northern Russia: Epidemiological Distinctions in the Results of a National Population Study

Cited by 8 publications

References 12 publications

Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017

Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017

Prevalence and Economic Burden of Respiratory Diseases in Central Asia and Russia: A Systematic Review

Time trends in smoking in Russia in the light of recent tobacco control measures: synthesis of evidence from multiple sources

Contact Info

Product

Resources

About